What is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s (603392.SS) StockRank?

MoatMap's StockRank for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) is 22/100, with a Sell signal. This is a composite score combining Quality (42), Value (41), and Momentum (29) factor ranks across MoatMap's 20,000+ stock universe.

Does Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. have an economic moat?

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) has a Quality factor score of 42/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) is Sell, based on a StockRank of 22/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. in?

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

603392.SS

SELLREMOVE

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. · Healthcare · China · $6.5B · Avg Vol: $28M/d

StockRank

P/E (TTM)

—

ROE

-3.3%

D/E

0.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Beijing Wantai Biological focuses on diagnostics and vaccines, lacking the high-moat, multi-client contract manufacturing characteristics of the CDMO pricing power theme.

COMPANY DESCRIPTION

Beijing Wantai Biological Pharmacy is a major biotechnology company specializing in infectious disease diagnostics and vaccine development, most notably producing China's first domestic HPV vaccine. The company enjoys a powerful competitive moat derived from its proprietary vaccine platforms, high regulatory barriers, and strong cost advantages over multinational competitors. It is a market leader in China's public health sector, with growing export potential for its WHO-prequalified products.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	1.7B	814M	332M	269M	-45.4%
EPS	0.56	0.15	0.01	-0.05	-85.5%
Shares	1.3B	1.3B	1.3B	1.3B	-0.3%
Debt	41M	46M	57M	52M	8.4%
Equity	1.8B	1.9B	1.8B	1.8B	-1.3%
Op CF	611M	227M	52M	13M	-72.1%
Inv CF	-519M	-304M	-222M	-112M	—
Fin CF	462M	-132M	-91M	69,708	—

PRICE (1M)-33.2%

SMA 50SMA 200

$4.23

RSI (14)

24.4

52W High

$11.82

From 52W High

0.4%

SCORE BREAKDOWN

Quality

ROIC

-3.9%40.3

ROE

-3.3%40.7

GP/Assets

5.7%19.6

Op. Margin

-10.9%29.1

FCF/Assets

-3.8%37.8

Piotroski

—28.7

Int. Cover

-50.0x6.4

D/E Ratio

0.03x78.8

Current Ratio

4.21x65.3

Value

P/E (TTM)

—N/A

EV/EBITDA

-81.7x95.5

P/FCF

—N/A

P/B

3.0x38.8

P/S

18.6x17.8

Div Yield

—N/A

Momentum

52W High %

36%9.4

RS 6M

-49%23.3

SMA 50/200

0.80x13.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—91.8

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$6.5B

P/E (Forward)

50.0x

Gross Margin

40.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 603392.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
603392.SS	Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.(you)	$6.5B	22	SELL
688180.SS	Shanghai Junshi Biosciences Co., Ltd.	$5.2B	25	SELL
300122.SZ	Chongqing Zhifei Biological Products Co., Ltd.	$4.8B	25	SELL
688796.SS	BIOCYTOGEN PHARMACEUTICALS (BEI	$7.2B	13	STRONG SELL
688266.SS	Suzhou Zelgen Biopharmaceuticals Co., Ltd.	$3.9B	28	SELL
002252.SZ	Shanghai RAAS Blood Products Co., Ltd.	$5.2B	34	SELL
688428.SS	InnoCare Pharma Limited	$6.4B	40	HOLD
9995.HK	RemeGen Co., Ltd.	$6.3B	40	HOLD
300255.SZ	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	$5.6B	6	STRONG SELL
300759.SZ	Pharmaron Beijing Co., Ltd.	$6.8B	44	HOLD

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) — Stock Score Summary

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) has a MoatMap StockRank of 22/100 based on Quality (42/100), Value (41/100), and Momentum (29/100) factor scores. The current signal is SELL. Beijing Wantai Biological focuses on diagnostics and vaccines, lacking the high-moat, multi-client contract manufacturing characteristics of the CDMO pricing power theme.

Key Financial Metrics

Price	$4.23
Market Cap	$6.5B
P/E (Forward)	49.98
Price/Book	3.05
Return on Equity	-3.3%
Return on Invested Capital	-3.9%
Debt/Equity	2.96
Gross Margin	40.7%
Operating Margin	-10.9%
Revenue Growth	30.6%
Free Cash Flow	$-12M

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.’s (603392.SS) StockRank?: MoatMap’s StockRank for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) is 22/100, with a Sell signal. It is a composite of Quality (42), Value (41), and Momentum (29) factor ranks across MoatMap’s 20,000+ stock universe.
Does Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. have an economic moat?: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) has a Quality factor score of 42/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) is Sell, based on a StockRank of 22/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. in?: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).